Evolent Health, Inc.
EVH
$9.41
-$0.13-1.36%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 31.75% | 8.64% | 104.65% | 13.52% | -194.40% |
| Total Depreciation and Amortization | 99.94% | -9.31% | -8.54% | 2.78% | 85.78% |
| Total Amortization of Deferred Charges | -19.62% | -14.70% | -22.25% | -15.29% | -35.67% |
| Total Other Non-Cash Items | -64.79% | -34.08% | -27.96% | 38.63% | 4,787.66% |
| Change in Net Operating Assets | -175.93% | -128.31% | -24.34% | 7.26% | 234.52% |
| Cash from Operations | -129.35% | -69.15% | 3,174.77% | 161.56% | 150.40% |
| Capital Expenditure | 142.48% | -154.51% | -70.46% | 25.65% | 43.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -3,536.62% | -14,507.69% | -481.68% | -100.00% |
| Cash from Investing | -229.31% | -221.06% | -62.09% | 97.54% | -35.82% |
| Total Debt Issued | -85.04% | -- | -- | -- | -- |
| Total Debt Repaid | 100.13% | 100.00% | -- | 98.59% | -- |
| Issuance of Common Stock | -- | -48.27% | -98.01% | -33.08% | 184.64% |
| Repurchase of Common Stock | 67.16% | 56.83% | -163.77% | -13.70% | -5.01% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 6.90% | -0.75% | -3.75% | -39.09% | -- |
| Other Financing Activities | 176.28% | 78.07% | -483.66% | 345.68% | -406.08% |
| Cash from Financing | 214.93% | 75.89% | -543.12% | -96.08% | -677.15% |
| Foreign Exchange rate Adjustments | -655.56% | 71.82% | -2,300.00% | -176.00% | 60.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4,965.03% | -159.76% | -711.23% | 143.22% | -105.12% |
